InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

0.4996
Delayed Data
As of 12:16pm ET
 -0.0203 / -3.90%
Today’s Change
0.45
Today|||52-Week Range
4.58
-35.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization740.7K752.0K689.0K553.0K
 
 
 
 
 
 
Operating ExpensesGross Income-740.7K-752.0K-689.0K-553.0K
 
 
 
 
 
General Expenses18.3M17.1M21.7M23.5M
 
 
 
 
 
Research And Development10.5M10.3M10.1M12.6M
 
 
 
 
 
Total Operating Expenses19.0M17.8M22.4M24.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.0M-17.8M-22.4M-24.1M
 
 
 
 
 
Extraordinary Credit----0.00593.0K
 
 
Extraordinary Charge-19.6M-376.0K-10.8M0.00
 
 
 
 
Interest Expense On Debt129.9K136.0K172.0K155.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-38.8M-18.3M-33.3M-23.4M
 
 
 
 
 
Net Income-38.8M-18.3M-33.3M-23.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.5M22.1M26.5M31.0M
 
 
 
 
 
Shares To Calculate EPS Diluted18.5M22.1M26.5M31.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.08-$0.84-$1.26-$0.76
 
 
 
 
 
EPS Diluted-$2.08-$0.84-$1.26-$0.76